TrialCancer gene therapy2002

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.

Christoph Rochlitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.